Status:

UNKNOWN

Partially-guided Protocol for Maxillary Overdentures Retained by Ti-Zr One-piece Mini Implants

Lead Sponsor:

Universidade Federal de Goias

Collaborating Sponsors:

ITI International Team for Implantology, Switzerland

Institut Straumann AG

Conditions:

Edentulous Jaw

Implant Complication

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

This is a single-center, single-group, prospective clinical trial testing a partially-guided protocol for placement of mini implants overdentures in the edentulous maxilla. Eligible participants will ...

Detailed Description

Design This is a single-center, single-group, prospective clinical trial testing a partially-guided protocol for placement of mini implants overdentures in the edentulous maxilla. Study setting, tria...

Eligibility Criteria

Inclusion

  • ≥ 60 years of age
  • healed dentulous maxillary arch (minimum of twelve weeks since the last extraction)
  • wearing a complete maxillary denture evaluated as sufficient for surgical planning
  • minimal ridge dimensions of 5.4 mm (width) by 12 mm (height) in the anterior and premolar maxillary area
  • bone dimensions allowing the placement of one-piece implants with a 2.4 mm-diameter and minimum length of 10 mm.
  • general health condition should be a physical status ASA1 or ASA2.

Exclusion

  • inability to perform adequate oral hygiene
  • incapability to provide written informed consent and compliance to the protocol
  • any contraindication for oral surgery such as but not limited to,
  • uncontrolled diabetes
  • immunosuppression
  • radiation or chemotherapy
  • antiresorptive medication such as bisphosphonates
  • presence of dental, periodontal or peri-implant disease in the opposing arch
  • presence of a conventional complete denture in the opposing arch (mandible)
  • presence of an insufficient partial removable denture or implant-overdenture in the opposing arch, which cannot be rendered sufficient by a reline
  • heavy smoking habit with \> 20 cig/d
  • reported severe bruxism or clenching habits
  • clinically present oro-facial pain
  • depression with a Geriatric Depression Scale above 12
  • xerostomia with a stimulated salivary flow rate inferior to 0.7 ml/min
  • ridge morphology type IV (Cawood and Howell, 1988)
  • defects requiring bone augmentation procedures, or unhealthy soft tissues.

Key Trial Info

Start Date :

January 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT06081192

Start Date

January 1 2024

End Date

December 1 2025

Last Update

October 13 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.